Compare OBT & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBT | BVS |
|---|---|---|
| Founded | 1892 | 2011 |
| Country | United States | United States |
| Employees | 225 | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 410.5M | 482.9M |
| IPO Year | 2021 | 2016 |
| Metric | OBT | BVS |
|---|---|---|
| Price | $30.88 | $8.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $36.00 | $14.25 |
| AVG Volume (30 Days) | 48.8K | ★ 306.1K |
| Earning Date | 05-05-2026 | 06-15-2026 |
| Dividend Yield | ★ 2.34% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | ★ 2.39 | 0.33 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $14.27 | $7.42 |
| Revenue Next Year | $7.99 | $6.46 |
| P/E Ratio | ★ $12.85 | $26.06 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $20.97 | $5.81 |
| 52 Week High | $37.99 | $10.13 |
| Indicator | OBT | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 34.17 | 52.81 |
| Support Level | $29.33 | $6.42 |
| Resistance Level | $31.49 | $9.01 |
| Average True Range (ATR) | 1.12 | 0.39 |
| MACD | -0.45 | -0.03 |
| Stochastic Oscillator | 24.76 | 34.81 |
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.